Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Streptococcus mutans biofilm and extracellular glucan matrix is a complex, three-dimensional biological structure that serves as the primary virulence factor in the development of dental caries (Koo et al., 2013, Nature Reviews Microbiology). Streptococcus mutans utilizes specialized glucosyltransferase enzymes (GTFs) to convert dietary sucrose into extracellular polymeric substances (EPS), specifically insoluble alpha-glucans, which facilitate firm bacterial adhesion to the tooth enamel and form a protective scaffold (Bowen & Koo, 2011, Caries Research). This matrix creates a diffusion-limited environment that traps organic acids produced by bacterial fermentation, leading to localized pH drops and subsequent enamel demineralization (Xiao et al., 2012, PLoS Pathogens). Therapeutic strategies targeting this matrix include the use of antimicrobial agents to reduce bacterial load, GTF inhibitors like apigenin to prevent matrix formation, and enzymes like mutanase to degrade the established EPS structure (Jeon et al., 2011, Caries Research). Beyond oral health, S. mutans biofilms can form on heart valves following bacteremia, contributing significantly to the pathogenesis of infective endocarditis (Nomura et al., 2020, Journal of Oral Biosciences). Effective management of this target requires disrupting the physical integrity of the matrix to enhance the penetration of traditional antimicrobial agents.
Inhibition of glucosyltransferase enzymes (GTFB, GTFC, GTFD) to prevent glucan synthesis, enzymatic degradation of existing extracellular polysaccharides (EPS) by glucanohydrolases, and direct antimicrobial activity against Streptococcus mutans cells to prevent initial attachment and subsequent biofilm maturation.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus mutans biofilm and extracellular glucan matrix (S. mutans biofilm).